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Prevention of Congenital Disorders
and Care of Affected Children
A Consensus Statement
Gary L. Darmstadt, MD; Christopher P. Howson, PhD; Gijs Walraven, MD; Robert W. Armstrong, MD;
Hannah K. Blencowe, MBChB; Arnold L. Christianson, FRCP Edin; Alastair Kent, MPhil; HelenMalherbe, MSc;
Jeffrey C. Murray, MD; Carmencita D. Padilla, MD; Salimah R. Walani, PhD; for the Participant Working Group of
the Dar es Salaam Seventh International Conference on Birth Defects and Disabilities in the DevelopingWorld
O n September 21-24, 2015, the eve of the announcementof theSustainableDevelopmentGoals (SDGs), stakehold-ers inadolescent,maternal,newborn,andchildhealthand
development from37 countries convened inDar es Salaam, Tanza-
nia, for the Seventh International Conference on Birth Defects and
Disabilities in theDevelopingWorld (ICBD) to discuss how to accel-
erate the prevention of congenital disorders (birth defects, ie, ab-
normalities of structureor function that arepresent frombirth) and
the improvement of care of affected children, especially in high-
burden, low-resource settings globally.1
This seventh conference, entitled Birth Defects in the Post-
MDG [Millennium Development Goals] Era: Joining Hands for Pre-
vention and Care, was organized by March of Dimes in partnership
with the Aga Khan Health Services–East Africa, the Aga Khan
University–East Africa, US Centers for Disease Control and Preven-
tion, and the Bill & Melinda Gates Foundation. Since the first ICBD
in 2001, each conference has been held in a different region of the
developing world, with the goal of bringing together experts and
stakeholders from the region and from around the world to dis-
cuss developments and highlight successes and issues to build
capacity in lower-income countries for the prevention of birth
defects and preterm birth and improvement of the care of those
affected. The conference description, call for abstracts, key dead-
lines, and related materials were sent out periodically via email
lists and the March of Dimes and Centers for Disease Control and
Prevention listservs.
The ICBDs were established to focus attention on the need to
improve theprevention and care of congenital disorders given that
theproportionofdeaths inchildrenyounger than5yearsduetocon-
genital disorders is rising in many low- and middle-income coun-
tries. In addition, rates of disability resulting from congenital disor-
ders are increasing in many countries where newborn survival is
improvingbutqualityhealthcare is lagging.Congenitaldisordersand
their associated disabilities result in a substantial emotional, social,
andeconomictollonaffected individuals, their families,andthecom-
munities inwhich they live. TheDar es Salaam ICBDwas assembled
to agreeonactions to reduce this toll, especially in vulnerable,mar-
ginalized populations. A draft consensus statementwas presented
anddiscussedbytheaudienceonthe lastdayof theconference,with
major changes incorporated at that time. The final document was
created by the authors and circulated to all conference partici-
pants,with 76providing input and supporting the consensus state-
ment. A working group was also established to explore additional
ways to put this statement into action.
We support accelerating the prevention of congenital disor-
ders and improvement of care of affected individuals, recognizing
that:
• An estimated 7.9 million children are born each year with a ge-
netic or partially genetic (multifactorial) congenital disorder, and
several hundred thousand more are born with congenital disor-
dersdueto inutero insultsafter conception, suchas infections, and
exposure to teratogens, such as alcohol.2,3
As the Sustainable Development Goals are adopted by United Nations member states,
children with congenital disorders remain left behind in policies, programs, research, and
funding. Although this finding was recognized by the creation and endorsement of the 63rd
World Health Assembly Resolution in 2010 calling on United Nations member states to
strengthen prevention of congenital disorders and the improvement of care of those
affected, there has been little to no action since then. The Sustainable Development Goals
call for the global health and development community to focus first and foremost on the
most vulnerable and those left behind in theMillennium Development Goal era. Tomaximize
the opportunity for every woman and couple to have a healthy child and to reduce the
mortality and severe disability associated with potentially avoidable congenital disorders and
their consequences for the children affected, their families and communities, and national
health care systems, we propose priority measures that should be taken urgently to address
this issue.
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• Of the 2.7million newbornswhodie annually,more than 1 in 10 die
ofacongenitaldisorder,and,overall, thereareanestimated484000
deaths due to congenital disorders among children younger than 5
years.4 This number is likely a gross underestimate, however, be-
cause many deaths due to congenital disorders, such as heart
defects andmetabolic disorders, go undetected.
• It is likely that more than 192000 of the 2.6 million annual still-
birthsmay result fromanunderlyingcongenital disorder.5Theper-
centageofstillbornchildrenaffectedbycongenitaldisorders is likely
much higher than for live births, andmany efforts to prevent still-
birthwillhelp reducetheoccurrenceofcongenitaldisordersamong
stillborn children.
• Mostnewbornswithaseriouscongenitaldisorderwhosurvive face
a lifetime of severe disability.2,3
• An estimated 94% of newborns with 1 or more congenital disor-
ders are born in low- andmiddle-income countries, placing an ad-
ditional severe burden on families, communities, and national
health care systems.2,3
• Up to an estimated 70% of congenital disorders are preventable
or their effect can be substantially mitigated and quality of life
improved, but these preventive andmitigating actions are occur-
ring almost exclusively in high-income settings.2,3
• The fact that childrenwith congenital disorders havebeen left be-
hind in policies, programs, research, and funding was recognized
by the creation and endorsement of the 63rd World Health
Assembly Resolution,6 calling in 2010 for United Nations mem-
ber states to (1) raise awareness of congenital disorders as a cause
of childmorbidity andmortality; (2) develop and strengthenbirth
registration and surveillance for birth defects; (3) strengthen evi-
denceonetiologic factors,diagnosis, andpreventionofmajorbirth
defects; and (4) develop national plans for implementation of ef-
fective interventions topreventandmanagebirthdefects.This call
by the World Health Organization, however, has gone unheeded
except in pockets such as Southeast Asia, where a strategic
framework7 is guiding efforts to prevent and control congenital
disorders in 12 countries of the region.
Theconferenceparticipants agreed that,with theadventof the
SDGs, greater emphasis must be placed on more holistic ap-
proaches, including preventive care and, beyond survival, optimi-
zation of childrens’ developmental potential. This emphasis aligns
with the SDGs’ call for equality in social inclusion and in opportuni-
ties for education, employment, and theability for all humanbeings
to fulfill their potential and enjoy prosperous, productive lives. Fur-
thermore, theSDGscall for givingpriority inpolicy andaction to the
most vulnerable, specifically including those with disabilities, and
those currentlymost left behind.8Congenital disorders canbecon-
sidered the first chronic disease experienced in life and are encom-
passed in SDG goal 3 that calls for a reduction, by 2030, by one-
third in premature mortality from noncommunicable diseases
through prevention and treatment and the promotion of mental
health and well-being.7
Call to Action
Tomaximize the opportunity for every woman and couple to have
a healthy child; to reduce the consequences of potentially avoid-
ablecongenitaldisorders for thoseaffected, their families, thehealth
care system, and the wider society; and to promote the well-being
of children who have a congenital disorder, there are many mea-
sures that shouldbe takenurgently toaddress this issue. In this con-
text and in order that no child is left behind, we pledge an initial
focus that supports the following:
Improving data quality:
1. Building consensus on and widespread use of a standardized
definitionofcongenitaldisorders, suchas “abnormalitiesof struc-
ture or function, which are present from birth,”3(p2) to facilitate
data comparison and ensure that the contribution of congenital
disorders to the burden of disease is comprehensively repre-
sented.
2. Establishing registries and surveillance systemsand their integra-
tion, where possible, into existing data platforms to monitor the
toll and risks of congenital disorders and evaluating the outcome
of interventionsforpreventionandcare.Considerationshouldalso
begiven to thecollectionofpertinentdataavailable fromexisting
registries and surveillance systems in other countries.
Reducing risk:
1. Promotingfamilyplanning,allowingwomenandcouplestochoose
when they have their first child, space their pregnancies, plan
family size, define the ages at which they wish to complete their
family, and reduce the proportion of unintended pregnancies.
2. Ensuringahealthy,balanceddiet forgirlsandduringawoman’s re-
productive years through an adequate intake of macronutrients
(protein, carbohydrates, and fats) and a broad range ofmicronu-
trients.Special attentionshouldbegiventoadding400μgofsyn-
thetic folic acid daily to the diet through fortification and supple-
mentation while also promoting a diet rich in food folates,
correcting iodinedeficiencythroughfortification,andensuringiron
sufficiency through fortification, supplementation, and therapy
for thosewith deficiencies.
3. Removing teratogenic substances from the diet, the most
important of which is alcohol, and minimizing environmental
contaminants in foods.
4. Controlling infections in women of reproductive age, including
rubella and syphilis, andoptimizingmaternal health throughde-
tection andmanagement of chronic illnesses associatedwith an
increased risk of congenital disorders, such as type 2 diabetes
mellitus and epilepsy, which require teratogenic medications.
Improving care:
1. Training physicians, nurses, allied health care professionals, and
workers in the fundamentalsof the recognition, causes, andcare
of children with congenital disorders and ensuring physical ex-
aminations of all newborns by trained health care professionals
before discharge from the hospital or clinic.
2. Aligning medical and social services to provide timely treat-
ments for congenital disorders, including surgery, medications,
dietarymodifications, and rehabilitation serviceswhenneeded.
3. Providing emotional and practical support for parents to enable
them to understand and manage their risk of congenital disor-
ders and to help families in supporting the growth and develop-
ment of children with congenital disorders.
Empowering the public and civil society:
1. Educating the public about congenital disorders and the steps
mothers and fathers can take with their health care profession-
als to maximize the chances of a healthy pregnancy.
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2. Strengthening civil society—including patient and parent sup-
port groups, faith-based groups, and nongovernmental organi-
zations—to advocate for improvedpreventionof congenital dis-
orders and access to high-quality, family-centered patient care,
including facilitatingcommunityandprofessional awarenessand
education and advocating for increased funding for research on
the causes of congenital disorders.
The following additional actions should be taken by countries as
priorities and circumstances allow:
1. Trainingphysicians, nurses, andalliedhealth careprofessionals in
theessentials ofmedical genetics. This training should includedi-
agnosisofcommoncongenitaldisordersbeforeandatbirth;means
of treatment where possible in the primary health care setting;
knowing when to refer a patient for more specialized treatment;
basicgenetic counseling, includingbestpractices incommunicat-
ingunfavorablehealthinformationtoparents;andsupportforfami-
lieswhohave a child or are at risk of having a childwith a congen-
ital disorder. Genetic counseling aims to empower thosewho are
counseled tomake autonomous decisions regarding their health
inways that are consonantwith their religious and ethical beliefs
and circumstances and to support them in their decisions.
2. Establishingpericonceptionmedical services toassistwomenand
theirpartners inattainingoptimalphysical andmentalhealthand
well-being and to facilitate a healthy pregnancy and delivery of
a healthy infant. These services include rubella immunization;
screening for the risk of genetic, partially genetic, and terato-
genic congenital disorders; andmentalhealthcounseling, includ-
ing identification and support for depression.
3. Implementing preconception or prenatal medical screening to
identifywomen and couples at risk of having a babywith hemo-
globin disorders; Down syndrome; blood type incompatibility;
congenital sexually transmitted infections such as syphilis, hu-
man immunodeficiencyvirus,andherpessimplexvirus;andstruc-
tural malformations, particularly neural tube defects.
4. Establishing newborn screening to identify congenital hypothy-
roidism, phenylketonuria, galactosemia, sickle cell disease,
glucose-6-phosphate dehydrogenase deficiency, and other
metabolic disorders.
5. Supporting research into thediagnosis, prevention, etiologic fac-
tors, and treatment of congenital disorders to enable improved
outcomes for children into the future.
The conference participants call for concerted action by inter-
national government policymakers and donor organizations to ex-
plorehowthese recommendedactionscanbe fundedthroughmore
cost-effective and rational integration of policy, funding, and inter-
ventionsacross thereproductive,maternal,newborn,child,andado-
lescent continuum. Systems are required that encourage more ef-
fective partnership among the many existing organizations and
agencies whose missions address common risk factors and out-
comesandwhowouldbenefit financiallyandprogrammatically from
better integrationofpolicy, research, andactionat international and
national levels.
Conclusions
The Seventh ICBD in Dar es Salaam, Tanzania, was a pivotal oppor-
tunity tobuild consensus and commitment for acceleratedpreven-
tionofcongenitaldisordersand improvementofcareofaffectedchil-
dren in low- andmiddle-income countries. In conjunction with the
newly launched SDGs and building on the 63rd World Health
Assembly resolution calling on United Nations member states to
strengthen prevention and care for congenital disorders, immedi-
ate action on the plan outlined above will save newborn and child
lives, reduce disability rates and improve quality of life in survivors,
and substantially lessen the current emotional andeconomic toll of
these conditions on affected individuals, their families, and the
communities in which they live.
ARTICLE INFORMATION
Accepted for Publication: February 9, 2016.
Published Online: June 27, 2016.
doi:10.1001/jamapediatrics.2016.0388.
Author Affiliations:March of Dimes Prematurity
Research Center, Department of Pediatrics,
Stanford University School of Medicine, Stanford,
California (Darmstadt); Department of Research
and Global Programs, March of Dimes Foundation,
White Plains, New York (Howson, Walani); Aga
Khan Development Network, Geneva, Switzerland
(Walraven); Department of Paediatrics, Faculty of
Health Sciences, Aga Khan University, East Africa,
Nairobi, Kenya (Armstrong); Centre for Maternal,
Adolescent, Reproductive, and Child Health,
London School of Hygiene and Tropical Medicine,
London, United Kingdom (Blencowe); Wits Centre
for Ethics, University of theWitwatersrand,
Johannesburg, South Africa (Christianson); Genetic
Alliance, London, United Kingdom (Kent); School
of Clinical Medicine, College of Health Sciences,
University of KwaZulu Natal, Durban, South Africa
(Malherbe); Division of Global Health, Bill & Melinda
Gates Foundation, Seattle, Washington (Murray);
Department of Pediatrics, College of Medicine,
University of the Philippines, Manila (Padilla).
Author Contributions:Drs Darmstadt and Howson
had full access to all the data in the study and take
responsibility for the integrity of the data and the
accuracy of the data analysis.
Study concept and design: All authors.
Acquisition, analysis, or interpretation of data:
Darmstadt, Howson, Blencowe,
Drafting of the manuscript:Darmstadt, Howson,
Blencowe, Christianson, Kent, Malherbe, Padilla.
Critical revision of the manuscript for important
intellectual content:Darmstadt, Howson, Walraven,
Armstrong, Blencowe, Malherbe, Murray, Walani.
Statistical analysis:Howson.
Obtained funding:Murray.
Administrative, technical, or material support:
Darmstadt, Howson, Walraven, Armstrong,
Malherbe, Murray, Walani.
Study supervision:Darmstadt, Howson,
Christianson.
Conflict of Interest Disclosures:None reported.
Funding/Support: The Seventh International
Conference on Birth Defects and Disabilities in the
DevelopingWorld was supported in part by a grant
from theMarch of Dimes Foundation, grant number
5U38OT000199 from the US Centers for Disease
Control and Prevention, and the Bill & Melinda
Gates Foundation (Investment ID OPP1129127).
Role of the Funder/Sponsor: The funding sources
had no role in the design and conduct of the study;
collection, management, analysis, and
interpretation of the data; preparation, review, or
approval of themanuscript; and decision to submit
themanuscript for publication.
Group Information: The ParticipantWorking
Group of the Dar es Salaam Seventh International
Conference on Birth Defects and Disabilities in the
DevelopingWorld members include Kjersti Aagaard
(Baylor College of Medicine); Neelam Aggarwal
(Postgraduate Institute of Medical Education and
Research, Chandigarh, India); Sujeewa Amarasena
(Sri Lanka College of Paediatricians, Sri Lanka);
Linda Barlow-Mosha (Makerere University, Johns
Hopkins University Research Collaboration,
Uganda); Muneerah Amin Vastani (Aga Khan
University, School of Nursing andMidwifery,
Tanzania); Eric Aswani Nyaligu (Technomed
Limited, Nairobi, Kenya, and Perkin Elmer
Distributors, Kenya); Tayo Awoyale, MD (Institute of
Child Health and Primary Care, Lagos University
Teaching Hospital, Lagos, Nigeria); Lieven Bauwens
(International Federation for Spina Bifida and
Hydrocephalus, Belgium); Martha Carvalho
(Brazilian Genetic Alliance, Brazil); Harish Chellani
(Department of Pediatrics, Safdarjang Hospital and
VardhmanMahavir Medical College, India); George
Clinical Review& Education Special Communication Prevention of Congenital Disorders and Care of Affected Children
792 JAMAPediatrics August 2016 Volume 170, Number 8 (Reprinted) jamapediatrics.com
Downloaded From:  by a London Sch of Hygiene & Tropical Medicine User  on 01/19/2018
Copyright 2016 American Medical Association. All rights reserved.
Cosmas (Ministry of Health and Social Welfare,
Tanzania); Sergio D’Agostino (Surgery for Children,
Humanitarian Association, Vicenza, Italy); Matthew
W. Darlison (World Health Organization
Collaborating Centre for Community Control of
Hereditary Disorders, University College
London Centre for Health Informatics and
Multi-professional Education, UK); Safiyya Devraj
(Aga Khan Health Services, Tanzania); Rym El Rafei
(American University of Beirut Medical Center,
Lebanon); Munda Elias (Kakonko District Council,
Tanzania); Martina Ens-Dokkum (Leiden University
Medical Center, Leiden, the Netherlands); Chinyere
V. Ezeaka (Neonatology Unit, Lagos University
Teaching Hospital, Surulere, Lagos, Nigeria); Itziar
Familiar-Lopez (Michigan State University); Lord
Jephthah Joojo Gowans (The Ghana Cleft Research
Project, Kwame Nkrumah University of Science and
Technology, Ghana); Abby Grant (Medical Genetics
Department, University Hospital of Northern
Norway, Norway); Shobhna Gupta (Vardhman
Mahavir Medical College and Safdarjung Hospital,
New Delhi, India); Petri Huhtinen (Perkin Elmer,
Africa, Finland); Fajolu Iretiola (College of Medicine,
University of Lagos, Lagos University Teaching
Hospital, Lagos, Nigeria); Kapila Jayaratne (Family
Health Bureau, Ministry of Health, Sri Lanka); Alix
Joseph (Perkin Elmer, France); Vijaya Kancherla
(Emory University Rollins School of Public Health);
Ajay Khera (Ministry of Health and Family Welfare,
India); Jill Levy-Fisch (Save Babies Through
Screening Foundation, USA); Desheng Liang
(State Key Laboratory of Medical Genetics, Central
South University, Changsha, China); Michele
Lloyd-Puryear (Save Babies Through Screening
Foundation and Parent Project Muscular Dystrophy,
USA); WilliamMacharia (Aga Khan University,
Nairobi, Kenya); Luis Madeira (Ministry of Health,
Mozambique); JerusalemMakotore Muburirwa
(Aga Khan Hospital, Dar es Salaam, Tanzania);
Leonard JamesMalasa (Hubert Kairuki Memorial
University, Dar es Salaam, Tanzania); Paola
Manduca (University of Genoa and NewWeapons
Research Group, Italy); Janet Manoni (Friends of
Children with Cancer, Tanzania); ShabaMichael
Kilasi (Ministry of Health and Social Welfare,
Tanzania); Franscesca Miquel-Verges (University of
Arkansas for Medical Sciences); Shaffiq Mohamed
(Aga Khan Hospital, Dar es Salaam, Tanzania); Lillian
Mtei (Muhimbili University of Health and Allied
Sciences, Tanzania); Edina Mullumba (Aga Khan
Health Service, Tanzania); Beata Mushema (Hubert
Kairuki Memorial University, Tanzania); Rachel
Musoke (University of Nairobi, Kenya); Wendy
Nembhard (Arkansas Reproductive Health
Monitoring System and University of Arkansas for
Medical Sciences, College of Medicine, Department
of Pediatrics, and Arkansas Children’s Hospital
Research Institute and Arkansas Center for Birth
Defects Research and Prevention); Margaret
Nguhi (Maternal, Neonatal and Child Health,
Kenya); Irmgard Nippert (Westfaelische
Wilhelms-Universitaet Muenster, Germany); Esther
Nyambura Njoroge (Smile Train, USA); John Nelson
Obondo (Buguruni Anglican Hospital, Tanzania);
Comrade Lawal-Aiyedun Olubunmi (Spina Bifida
and Hydrocephalus Care Foundation, Nigeria);
Rebecca Opetsi Alitsi (Wezesha Kupaa: Youth
With a Mission, Tanzania); Helena Pachón (Food
Fortification Initiative, USA); Ysbrand Poortman
(Preparing for Life Collaboration, the Netherlands);
Charles Powell (Children’s Hospital, Zinga,
Tanzania); Lynne Powell (Rockford Memorial
Hospital, USA); Neena Raina (Maternal, Newborn,
Child and Adolescent Health, World Health
Organization, Southeast Asia Regional Office,
India); Rajarajeswari K (Sri Ramachandra University,
India); Nagy Sabet (Misr University for Science and
Technology, Egypt); Henry Safori (Ghana Health
Service, Ghana); Rogath Saika Kishimba (Ministry
of Health and Social Welfare, Field Epidemiology
and Laboratory Training Program, Tanzania);
Abdulhakim Salim Bayakub (The Registered
Trustees of ASSAS Trust, Dar es Salaam, Tanzania);
Hilal Salum (Comprehensive Community Based
Rehabilitation in Tanzania, Tanzania); Florence
Salvatory (Hubert Kairuki Memorial University,
Tanzania); Switbert Sambala (Aga Khan Hospital,
Dar es Salaam, Tanzania); Maria Teresa Vieira
Sanseverino (Medical Genetics Service, Hospital
De Clinicas De Porto Alegre, Brazil); Vivian Saria
Frank (Kilimanjaro Christian Medical College,
Tanzania); Iran Sayed-Raeisy (Aga Khan Health
Services, Dar es Salaam, Tanzania); Neema Seya
(MyRight–Empowers People with Disabilities,
Tanzania); Hamisi Kimaro Shabani (Muhimbili
Orthopedic Institute Department of Neurological
Surgery, Tanzania); Alice Shalua (Bugando School of
Nursing, Tanzania); Bradford Therrell (US National
Newborn Screening and Global Resource Center,
Texas); John Tole (Aga Khan University, Nairobi,
Kenya); Christine Tusiime (CoRSU Rehabilitation
Hospital, Uganda); W. K. N. Weliwagamage (Family
Health Bureau, Sri Lanka); D. L. Woods (Perinatal
Education Trust, South Africa); and LingqianWu
(Center of Prenatal Diagnosis, Xiangya Hospital
Central South University, Changsha, China).
Additional Contributions:Megan Bruno and Randi
Roberts, March of Dimes Foundation, provided
administrative support in the preparation of the
manuscript. They were not compensated for their
contribution.
REFERENCES
1. March of Dimes. 7th International Conference on
Birth Defects in the DevelopingWorld. http://icbd
.marchofdimes.org/. Accessed October 1, 2015.
2. Christianson A, Howson C, Modell B.March of
Dimes Global Report on Birth Defects: The Hidden
Toll of Dying and Disabled Children. White Plains, NY:
March of Dimes Birth Defects Foundation; 2006.
3. March of Dimes, World Health Organization.
Management of Birth Defects and Haemoglobin
Disorders: Report of a Joint WHO-March of Dimes
Meeting. Geneva, Switzerland: World Health
Organization; 2006.
4. Liu L, Oza S, Hogan D, et al. Global, regional, and
national causes of child mortality in 2000-13, with
projections to inform post-2015 priorities: an
updated systematic analysis. Lancet. 2015;385
(9966):430-440.
5. Lawn JE, Blencowe H,Waiswa P, et al; Lancet
Ending Preventable Stillbirths Series Study Group;
Lancet Stillbirth Epidemiology Investigator Group.
Stillbirths: rates, risk factors, and acceleration
towards 2030. Lancet. 2016;387(10018):587-603.
6. World Health Organization. Birth defects. http:
//apps.who.int/gb/ebwha/pdf_files/WHA63/A63
_R17-en.pdf. PublishedMay 21, 2010. Accessed
October 1, 2015.
7. World Health Organization. Prevention and
Control of Birth Defects in South-East Asia Region:
Strategic Framework (2013-2017). New Delhi, India:
World Health Organization; 2013.
8. United Nations Department of Economic and
Social Affairs. Sustainable development topics.
https://sustainabledevelopment.un.org/topics.
Accessed October 1, 2015.
Prevention of Congenital Disorders and Care of Affected Children Special Communication Clinical Review& Education
jamapediatrics.com (Reprinted) JAMAPediatrics August 2016 Volume 170, Number 8 793
Downloaded From:  by a London Sch of Hygiene & Tropical Medicine User  on 01/19/2018
